Sanjeev Krishna is an expert in Infectiology at Universitätsklinikum Tübingen (Germany). As of September 2026, ScienceLeadR ranks Sanjeev Krishna in the top 1% of experts worldwide for Mosquito-Borne Diseases. Sanjeev Krishna has authored 364 publications, the most recent in 2026, and is an investigator in 6 clinical trials. SLR score: 1,088 (community average: 125). How the SLR is computed.

LeadR Profile

Sanjeev Krishna Universitätsklinikum Tübingen Germany
1 088 ScienceLeadR Reputation 1088
Network Map

Infectiology

Subspecialties: Public Health - Obstetrics - Gynecology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Sanjeev Krishna is Professor of Molecular Parasitology and Medicine at St. George’s, University of London’s Institute for Infection and Immunity. His research interests encompass cellular, molecular and clinical studies on neglected diseases. He works on understanding how antimalarials kill parasites, how parasites become resistant to different classes of antimalarial, and on discovery studies for new antimalarials and new drug targets. He also studies pathophysiology and treatment of malaria. He has worked on vaccines for Ebola virus disease and on optimising management of COVID19 through improving diagnostics. He has also repurposed artesunate for the management of several cancers. He is a Fellow of the Academy of Medical Sciences.


Organizations

Career arc: 1989 - 2026

Source: PubMed

St George's, University of London

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 364

Citations

Citations: 23 476 1st author: 45 Last author: 88 Unique author: 4


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Association between COVID-19 status and Leydig cell functional capacity among men in hospitalized cohorts.
PMID 41902764 — cells, hypogonadism, sars-cov-2, leydig cells, biomarkers, testosterone, signs and symptoms, covid-19, therapeutics, testis
Aging Male20260
"Now that the baby is out, I can be vaccinated": a qualitative study on COVID-19 vaccine hesitancy in pregnant women in Kilifi, Kenya.
PMID 41725768 — pregnant women, pregnancy, prenatal care, vaccines, covid-19 vaccines, public health, vaccination, community health workers, covid-19, vaccination hesitancy
Front Public Health20260
Artesunate-pyronaridine-atovaquone-proguanil and artesunate-fosmidomycin-clindamycin compared with standard artesunate-pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and Ghana.
PMID 41616788 — malaria, proguanil, clindamycin, safety, pharmaceutical preparations, atovaquone, aged, drug-related side effects and adverse reactions, adolescent, therapeutics, antimalarials, artesunate
Lancet Microbe20260
Understanding knowledge, beliefs, values and barriers towards cervical cancer screening and self-sampling amongst migrant Muslim women in Southwest London: an in-depth qualitative interview study.
PMID 41561556 — uterine cervical neoplasms, neoplasms
BMJ Public Health20260
Isothermal Recombinase Polymerase Amplification based diagnostics for Female Genital Schistosomiasis and Human Papillomavirus: A Review of Combined Molecular Diagnostic Opportunities.
PMID 41287386 — genitalia, female, schistosomiasis, recombinases, parasitic diseases, alphapapillomavirus, parasitology, human papillomavirus viruses
Parasitology20250

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 3
Phase 2 2
Phase 1 1

By status:

Completed 4
Recruiting 1
Unknown 1

By type:

Interventional 4
Observational 2

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 1
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 9

LeadR Networks

Main global connection map